EUVIMEDEUVIMED entdecken
Editorial

Early detection of subclinical cardiac amyloidosis: the importance of increasing physician awareness and routine imaging assessment

Christoph Gräni

The International Journal of Cardiovascular Imaging · 2024

DOI: 10.1007/s10554-024-03148-1 ↗

Kurz gefasst

Editorial in der Zeitschrift The International Journal of Cardiovascular Imaging, 2024. Verfasst von Christoph Gräni. Beteiligte Einrichtung: Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland. christoph.graeni@insel.ch. Hauptthemen laut MEDLINE: Predictive Value of Tests, Early Diagnosis, Cardiomyopathies, Asymptomatic Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Predictive Value of TestsEarly DiagnosisCardiomyopathiesAsymptomatic DiseasesHumansAmyloidosisHealth Knowledge, Attitudes, PracticePrognosis

Autor:innen und Institutionen

  • Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland. christoph.graeni@insel.ch.

Zitieren

APA

Gräni, C. (2024). Early detection of subclinical cardiac amyloidosis: the importance of increasing physician awareness and routine imaging assessment. The International Journal of Cardiovascular Imaging. https://doi.org/10.1007/s10554-024-03148-1

Vancouver

Gräni C. Early detection of subclinical cardiac amyloidosis: the importance of increasing physician awareness and routine imaging assessment. The International Journal of Cardiovascular Imaging. 2024. doi:10.1007/s10554-024-03148-1

BibTeX
@article{Grni2024,
  author = {Gräni, Christoph},
  title = {Early detection of subclinical cardiac amyloidosis: the importance of increasing physician awareness and routine imaging assessment},
  journal = {The International Journal of Cardiovascular Imaging},
  year = {2024},
  doi = {10.1007/s10554-024-03148-1}
}
Kostenlos starten →